IP Library Patent Application 11443693
Patent Application
App. No. 11/443,693

Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/443,693
Abstract

Compounds of the formula (I) a process for their preparation and their use as medicaments are described.

Claims (51)

1 . (canceled)

2 . (canceled)

3 . (canceled)

4 . (canceled)

5 . (canceled)

6 . (canceled)

7 . (canceled)

8 . (canceled)

9 . (canceled)

10 . A method for the treatment of disorders of the urogenital region and cancer comprising administering to a patient in need thereof an effective amount of a compound of formula (I)

in which

n represents a number 2, 3 or 4,

R 1 represents hydrogen or (C 1 -C 4 )-alkyl

and

R 2 represents pyridyl or thiazolyl which for its part may be substituted by (C 1 -C 4 )-alkyl, halogen, amino, dimethylamino, acetylamino, guanidino, pyridylamino, thienyl, furyl, imidazolyl, pyridyl, morpholinyl, thiomorpholinyl, piperdinyl, piperazinyl, N—(C 1 -C 4 )-alkylpiperazinyl, pyrrolidinyl, oxazolyl, isoxazolyl, pyrimidinyl, pyrazinyl, optionally (C 1 -C 4 )-alkyl-substituted thiazolyl or phenyl which is optionally substituted up to three times by halogen, (C 1 -C 4 )-alkyl or (C 1 -C 4 )-alkoxy,

or a pharmaceutically acceptable salt, hydrate, hydrate of a salt, or solvate thereof.

11 . A method for the treatment of inflammatory and neuroinflammatory disorders, neurodegenerative disorders and pain comprising administering to a patient in need thereof an effective amount of a compound of formula (I)

in which

n represents a number 2, 3 or 4,

R 1 represents hydrogen or (C 1 -C 4 )-alkyl

and

R 2 represents pyridyl or thiazolyl which for its part may be substituted by (C 1 -C 4 )-alkyl, halogen, amino, dimethylamino, acetylamino, guanidino, pyridylamino, thienyl, furyl, imidazolyl, pyridyl, morpholinyl, thiomorpholinyl, piperidinyl, piperazinyl, N—(C 1 -C 4 )-alkylpiperazinyl, pyrrolidinyl, oxazolyl, isoxazolyl, pyrimidinyl, pyrazinyl, optionally (C 1 -C 4 )-alkyl-substituted thiazolyl or phenyl which is optionally substituted up to three times by halogen, (C 1 -C 4 )-alkyl or (C 1 -C 4 )-alkoxy,

or a pharmaceutically acceptable salt, hydrate, hydrate of a salt, or solvate thereof.

12 . The method of claim 10 , wherein the compound of formula (I) is characterized

n represents the number 2,

R 1 represents hydrogen, methyl or ethyl,

and

R 2 represents pyridyl or thiazolyl which for its part may be substituted by methyl, ethyl, fluorine, chlorine, amino, dimethylamino, acetylamino, guanidino, 2-pyridylamino, 4-pyridylamino, thienyl, pyridyl, morpholinyl, piperidinyl, optionally methyl-substituted thiazolyl or phenyl which is optionally substituted up to three times by chlorine or methoxy,

or a pharmaceutically acceptable salt, hydrate, hydrate of a salt, or solvate thereof.

13 . The method of claim 10 , wherein the compound of formula (I) is characterized

n represents the number 2,

R 1 represents hydrogen or methyl

and

R 2 represents pyridyl or thiazolyl which for its part may be substituted by methyl, chlorine, amino, dimethylamino, acetylamino, guanidino, 2-pyridylamino, 4-pyridylamino, thienyl, pyridyl, morpholinyl, 2-methylthiazol-5-yl, phenyl, 4-chlorophenyl or 3,4,5-trimethoxyphenyl,

or a pharmaceutically acceptable salt, hydrate, hydrate of a salt, or solvate thereof.

14 . The method of claim 10 , wherein the compound of formula (I) has the following structure

or a pharmaceutically acceptable salt, hydrate, hydrate of a salt, or solvate thereof.

15 . The method of claim 11 , wherein the compound of formula (I) is characterized

n represents the number 2,

R 1 represents hydrogen, methyl or ethyl,

and

R 2 represents pyridyl or thiazolyl which for its part may be substituted by methyl, ethyl, fluorine, chlorine, amino, dimethylamino, acetylamino, guanidino, 2-pyridylamino, 4-pyridylamino, thienyl, pyridyl, morpholinyl, piperidinyl, optionally methyl-substituted thiazolyl or phenyl which is optionally substituted up to three times by chlorine or methoxy,

or a pharmaceutically acceptable salt, hydrate, hydrate of a salt, or solvate thereof.

16 . The method of claim 11 , wherein the compound of formula (I) is characterized

n represents the number 2,

R 1 represents hydrogen or methyl

and

R 2 represents pyridyl or thiazolyl which for its part may be substituted by methyl, chlorine, amino, dimethylamino, acetylamino, guanidino, 2-pyridylamino, 4-pyridylamino, thienyl, pyridyl, morpholinyl, 2-methylthiazol-5-yl, phenyl, 4-chlorophenyl or 3,4,5-trimethoxyphenyl,

or a pharmaceutically acceptable salt, hydrate, hydrate of a salt, or solvate thereof.

17 . The method of claim 11 , wherein the compound of formula (I) has the following structure

or a pharmaceutically acceptable salt, hydrate, hydrate of a salt, or solvate thereof.

Assignments (2)
MERGER Recorded Jan 12, 2010
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 023769/0122 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2009
From: ROSENTRETER, ULRICH; KRAMER, THOMAS; SHIMADA, MITSUYUKI; HUBSCH, WALTER; DIEDRICHS, NICOLE; KRAHN, THOMAS; HENNINGER, KERSTIN; STASCH, JOHANNES-PETER; WISCHNAT, RALF
To: BAYER HEALTHCARE AG
Reel/Frame 023466/0399 →